ClinicalTrials.gov
public full text
Public Domain
Evaluating the Efficacy of Dextromethorphan/Quinidine in Treating Irritability in Huntington's Disease
The purpose of this study is to assess efficacy and safety of dextromethorphan/quinidine 20mg/10mg (DM/Q 20mg/10mg) in patients with irritability due to Huntington's disease.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Safety Evaluation of Cellavita HD Administered Intravenously in Participants With Huntington's Disease#1140550
- Pilot Study of Minocycline in Huntington's Disease#874265
- ED50 of Dexmedetomidine to Prevent Emergence Agitation in Children#886899
- Multi-Modal Digital Monitoring of Disease Symptoms Huntington's Disease#914952
- Impact of Upper Limb Function on Activities of Daily Living and Quality of Life in Huntington’s Disease#355444
Record · ID 830607
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive